The majority of prostate epithelial cell lines stably expressing wild-type (wt) or mutant (mt) androgen receptor (AR) are derived from metastatic prostate cancers. Therefore, the wt ARexpressing RC-165N/human telomerase reverse transcriptase (hTERT) cell line derived from the benign prostate tissue of an African-American patient provides a unique opportunity to assess the functional status of AR in a cellular context not studied before. Although androgen-induced expression of known androgen responsive genes such as PMEPA1, and NDRG1 was observed in RC-165N/hTERT, this cell line expresses prostate-specific antigen (PSA) at significantly lower levels. Chromatin immunoprecipitation assay revealed androgen-dependent binding of AR to androgen response elements of PSA, PMEPA1 and NDRG1 genes. Similarities, as well as differences were noted in the expression of androgen responsive genes between RC-165N/hTERT and LNCaP cells. Comprehensive evaluations of AR functions in RC-165N/hTERT cells suggest that whereas some features of known AR functions are maintained in this benign prostatic tissuederived cell line, other AR functions are not retained. Objective evaluations of similar cell lines will lead to the understanding of AR functions in prostate growth and differentiation.
Introduction
Carcinoma of the prostate (CaP) is the most common non-cutaneous malignancy and the third leading cause of cancer-related deaths in American males. 1 However, a large part of the molecular mechanisms of prostate tumorigenesis remains to be defined. Cell culture models effectively representing in vivo characteristics of CaP can greatly facilitate research focusing on prostate cancer biology. Although, several metastatic tissue-derived CaP cell models are being extensively used such as LNCaP, LAPC4, PC-3 and DU-145, there is a continued need for the establishment of in vitro models derived from benign and primary prostate cancer tissues. We and others have recently reported establishment of new cell lines from benign and primary prostate cancer tissues. [2] [3] [4] [5] [6] Prostate cancer is a major health concern in older American males with higher incidence in AfricanAmerican males, with almost twice the morbidity as Caucasian American males. 7 Therefore, the establishment of in vitro cell models isolated from African-American patients may contribute to better understanding of the biology of prostate growth as well as prostate cancer of African-American men. Among previously established prostate cell lines, only a few were established from African-American patients: MDA PCa 2a and 2b, 8 
E006AA
4 and the RC-165N/human telomerase reverse transcriptase (hTERT). 2 The MDA cell lines were derived from advanced androgen-independent prostate cancer of a metastatic bone tumor. 8 Another recently established cell line, the E006AA was derived from a pathologically confined tumor of an African-American patient, and this cell line may represent the characteristics of localized human prostate cancer. 4 We have recently reported the establishment of a cell line (RC-165N/hTERT) from a histologicaly defined benign tissue of African-American patient using overexpression of hTERT 2, 3 Assessment of expressed markers in RC-165N/hTERT indicated luminal characteristics. 3 This cell line constitutively expressed wild-type (wt)-androgen receptor (AR) protein and responded to both androgen hormone stimuli and AR antagonist (flutamide). As, stable AR expression represents unique feature of this benign tissue-derived immortalized prostatic epithelial cells, here we report the evaluation of AR downstream functions in RC-165N/ hTERT cells.
In this report, we examined the AR binding to androgen responsive elements within the promoter regions of androgen-regulated genes. Quantitative expression of the representative androgen responsive genes was also evaluated by quantitative polymerase chain reaction (QPCR) and supersensitive enzyme-linked immunosorbent assay (ELISA) assays. Furthermore, we examined the features of AR-signaling pathways using temporal gene expression profiles in response to DHT.
Materials and methods

Cell culture and androgen treatment
Epithelial cells (RC-165N) were derived from benign prostate tissue of an African-American patient who underwent radical prostatectomy. Tissue sections adjacent to tissues used for cell culture showed histological features of benign non-malignant prostate glands. Primary cultures were established according to Walter Reed Army Medical Center (WRAMC) and Uniformed Services University of the Health Sciences Internal Review Board (USU IRB) protocols by the explantoutgrowth method as described in elsewhere. 2 For serial passages, routine trypsinization was used. Keratinocyte serum-free medium (Cat. 10724-011, LifeTechnologies, Gaithersburg, MD, USA) supplemented with bovine pituitary extract (BPE), recombinant epidermal growth factor (rEGF), 1% (v/v) penicillin-streptomycin-neomycin (PSN) antibiotic mixtures and 1% (v/v) amphotericin B (LifeTechnologies, Gaithersburg, MD, USA) were used for growing and maintaining the cells and designated as KGM medium. 2 For androgen treatment experiment, BPE and rEGF were replaced by 0.1% bovine serum albumin solution (Sigma, St Louis, MO, USA). Both DHT (0, 1.0, 10 and 100 nM) (Sigma, St Louis, MO, USA) and R1881 (10 nM) (Perkin Elmer, Boston, MA, USA) were sequentially diluted by absolute ethanol to desired concentration, and the final concentration of ethanol in the cell culture was adjusted to 0.1% (v/v) in control and hormone-treated cultures. After treating the cells with androgen at approximately 50% confluence, the cells were allowed to grow in an incubator at 371C with 5% humidity and 5% CO 2 for 48 h. Cells were then processed for chromatin immunoprecipitation (ChIP), real-time reverse transcription (RT)-PCR and GeneChip experiments. The cell culture medium treated with DHT or R1881 for 120 h (5 days) were used for prostate-specific antigen (PSA) protein detection with the Super-ELISA system, which employed the multi-photon detection methods in ELISA setup. 9, 10 LNCaP was maintained in Rosewell Park Memorial Institute medium (Invitrogen, Carlsbad, CA, USA).
Immunoblot analysis
Total proteins of the RC-165N/hTERT cells without androgen treatment were extracted with a commercial lysis buffer (T-PER, Pierce, IL, USA) including protease inhibitor mixtures (Complete Mini, Roche, IN, USA). To detect AR protein with immunoblot, 30 mg of total proteins were separated in a 4-12% gradient gel (Invitrogen, Carlsbad, CA, USA). Proteins were transferred to a polyvinylidene difluoride membrane (Invitrogen), then membranes were blocked in 10% non-fat dry milk (Bio-Rad, Hercules, CA, USA) in 1 Â phosphatebuffered saline (PBS) including 0.1% Tween-20 for 1 h, and incubated with anti-AR primary antibodies (SC-7305, Santa Cruz Biotech, CA, USA) at 150 Â dilution for 1.5 h at room temperature. The blots were washed and then incubated with horseradish peroxidase-conjugated secondary antibodies (Amersham Pharmacia Biotech, NJ, USA) at a dilution of 1:5000 for 1 h at room temperature. After washing, the blots were developed with the Enhanced Chemiluminescence kit according to the manufacturer's instructions (Amersham Biosciences, Piscataway, NJ, USA).
ChIP in prostate cell cultures
ChIP procedures [11] [12] [13] were modified to adopt the protocols to prostate cell cultures. RC-165 N/hTERT cells (0.5 Â 10 6 ) were washed twice with ice-cold PBS and were harvested in ice-cold 1 Â PBS, pH 7.4 containing 1% formaldehyde and Complete Mini protease inhibitors (Roche) and collected by centrifugation. Cells were incubated at 371C for 15 min to complete the chemical crosslinking reaction. The reaction was stopped by washing the cells three times with 0.5 ml of PBS at 41C The cells were lysed by 0.5 ml RT lysis buffer (50 mM TrisHCl, pH 8.1, 10 mM ethylenediaminetetraacetic acid (EDTA), 1% sodium dodecyl sulphate (SDS) and Complete Mini protease inhibitor), which was followed by incubation on ice for 10 min. To disintegrate the cells by sonication we used VisSonic 100 sonicator (VITRIS). We applied 10-s bursts at energy level four on ice followed by 30 s cooling on ice for a total of four times. The suspension was diluted 10-fold with dilution buffer (16.7 mM Tris-HCl (pH 8.1), 167 mM NaCl, 0.01% SDS, 1.1% Triton-X 100, 1.2 mM EDTA and Complete Mini protease inhibitors). The suspension was precleared with 40 ml of 50% protein A/G-coupled sepharose bead slurry (PIERCE, Rockford, IL, USA) by rotating for 1 h at 41C before the experiment. One microgram aliquot of an equal volume mixture of anti-AR antibodies H-280 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), PG-21 (Upstate, Lake Placid, NY, USA) and AR441(Alexis Biochemicals, Lausen, Switzerland) were incubated with the chromatin suspension 12 h at 41C. The immunoprecipitated chromatin was recovered by A/G-coupled sepharose beads. The beads were washed and the DNA was released by digesting the samples with Proteinase K (Roche, Indianapolis, IN, USA) for 12 h at 241C. The crosslinks were reverted by incubating the samples at 651C for 6 h and the proteins were removed by phenol/ chloroform extraction. The DNA was recovered by ethanol precipitation and dissolved in 100 ml of Tris-EDTA buffer (10 mM Tris-HCl (pH 7.5), 1 mM EDTA). ARbinding sites within the promoter regions of PMEPA1, NDRG1 and PSA (KLK3) genes were predicted in silico by the Genomatix Software (www.genomatix.de). PCR primers were designed by the Primer3 program of the Whitehead Institute.
14 To amplify the predicted PMEPA1 0 primers were used for amplifying the PSA/AREIII (À3999) element. PCR was carried out in 43 cycles for ChIP products and in 38 cycles for input DNA. Each cycle included 10 s denaturation at 941C, 15 s annealing at 501C and 60 s extension at 721C. The PCR products were separated on 2.5% agarose gel by electrophoresis along with a 100 kb molecular weight ladder.
Reverse transcription and real-time PCR
Total RNA from cell cultures was isolated by the RNAzol B (Tel-Tes Inc., Friendswood, TX, USA) method. Two micrograms of total RNA were used in the reverse transcription reaction, by using random hexamer primer and Omniscript reverse transcriptase (Qiagen, Germantown, MD, USA) in 20 ml reaction volume, following the supplier's recommendations. PCR primers and probes for PSA, PSMA and NDRG1 were designed by Primer Express software (Applied Biosystems, Foster City, CA, USA). Each 30 ml volume of the PCR reaction included 2 ml 2 Â diluted cDNA (equal 100 ng RNA), 300 nM sense primer, 300 nM antisense primer, 225 nM 6 0 -FAM-labeled fluoresce target probes, 1.5 ml 20Â glyceraldehyde-3-phosphate dehydrogenase (GAPDH) endogenous control (primers plus VIC-labeled probe) and 15 ml Universal Master Mixture (Applied Biosystems, Foster City, CA, USA). The PCR reactions were run in ABI PRISM 7700 sequence detection system. PCR amplification included one stage at 501C 2 min, one step at 951C for 10 min and 50 cycles at 951C for 15 s and 601C for 30 s two-step PCR, triplicate RT-PCR reactions and one control reaction without RT (No-RT) were performed for each gene. Amplification of an endogenous control was performed in same well to standardize the amount of the expression target RNA. The CT data in real-time PCR is used to determine D CT, DD CT and the relative amount of the target messenger RNA (mRNA). The formula for expression of targets mRNA: 2 ÀDDCT The D CT is obtained by subtracting the average GAPDH CT from the average target gene CT, DD CT is obtained by subtracting the D CT from the target gene in treated DHT to untreated control samples.
Primers and probes used for quantitative RT-PCR amplification of PSA were as follows: Sense: CCCACTG CATCAGGAACAAA. Antisense: GAGCGGGTGTGGG AAGCT. Probe: 6FAM-ACACAGGCCAGGTATTTCAGG TCAGCC-TAMRA. PSMA probes were as follows. Sense: GGCGCTGGTGCTGGC. Antisense: CAATTCATCCAA AAATGCTTTCAT. Probe: 6FAM-TCGGCTTCCTCTTCG GGTGGTTTATAAAATCC-TAMRA. Probes to detect NDRG1 expression were as follows. Sense: GCCAGCA CATTGTGAATGACA. Antisense: GCAGGGTGACTG TGTGGGTT. Probe: 6FAM-AATGCCTACAACAGCCGG CGCGA-TAMRA.
GeneChip analysis
Total RNA was used to hybridize to high-density oligonucleotide human genome array HG U133A GeneChip (Affymetrix, Santa Clara, CA, USA) that contains 22 283 probe sets which represented about 18 000 annotated genes and the rest represented expressed sequence tags and hypothetical genes. Biotinylation of complementary RNA (cRNA), purification of the . The expression levels of individual genes were normalized to the expression of GAPDH. Each experiment was carried out triplicate and was repeated twice.
AR functions in an African-American benign cell line K-H Kim et al biotinylated cRNA, fragmentation of the probes, hybridization, staining and scanning of the hybridized GeneChips were carried out as described earlier. 15 For Image Analysis and data extraction Affymetrix GeneChip Microarray Analysis Software, version 3.1, Affymetrix Micro DB, Data Mining Tool version 2.0 (Affymetrix, Santa Clara, CA, USA), Microsoft Excel 2000 (Microsoft, Seattle, WA, USA) and Statistica version 4.1 (Stat Soft Inc., Tulsa, OK, USA) were used. For further details and advanced bioinformatic analysis we used the GeneSpring software (Silicon Genetics, CA, USA) as we previously described. 16 Pathway analysis was performed by the Ingenuity Pathway Analysis Software (Ingenuity, Mountain View, CA, USA).
Results
RC-165N/hTERT cells express AR protein and AR regulates the expression of downstream target genes
AR protein was detected in RC-165N/hTERT cells by immunoblot assay. The results of the assay were consistent with our previous report on AR mRNA expression in RC-165N/hTERT cells where we reported the presence of several prostate-epithelial markers in this cell line 2,3 ( Figure 1 ). To assess the integrity of the AR pathway, gene expression levels of AR-regulated genes were screened using QPCR. PSMA and NDRG1 16 were selected, and then examined as representatives for the integrity of AR-pathway. Consistent with previous reports, quantitative assessment of DHT-responsive PSMA gene expression revealed a dose-dependent downregulation in response to DHT. 17 Although NDRG1 gene expression was previously reported to reach saturation levels at 10 À9 -10 À8 M 18 and our data on NDRG1 showed modest decrease (B0.2-fold decrease) at 10
À8 M compared to 10 À9 M DHT, its expression in the RC-165N/hTERT cells was generally upregulated by increasing DHT, which was similar to the previous observations. 16, 18 Figure 2 ChIP assay reveals AR binding to PMEPA1, NDRG1 and PSA(KLK3) promoter upstream sequences. Specific sets of primer pairs were selected in order to amplify the regions of predicted ARE sequences within the PMEPA1 (a), PSA(KLK3) (b) and NDRG1 (c) genes. To achieve linear amplifications ranges the ChIP and input products were amplified with 43 and 38 cycles, respectively. 
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Wt AR in RC-165N/hTERT cells binds to specific androgen responsive elements
To examine AR binding to androgen responsive elements of target gene promoter regions, ChIP assay was performed assessing AREs of PSA (KLK3), PMEPA1 and NDRG1 gene upstream sequences in DHT treated or untreated cells. A distal ARE element (À2134) of the PMEPA1 gene promoter showed AR binding in DHTinducible manner whereas AR binding was not detected at the proximal region (À230) (Figure 2a) . Furthermore, ChIP assay revealed DHT-dependent binding of AR to the ARE (À984) of NDRG1 promoter (Figure 2b) . Interestingly, AR-binding was detected in non-stimulated cells at the AREIII of PSA (KLK3) gene enhancer that was somewhat decreased by the addition of DHT (Figure 2c) .
Expression of PSA
Using conventional Northern blot and Immunoblot methods, the detection of PSA protein expression from RC-165N/hTERT cells was previously not feasible. 2 However, with the Super-ELISA system that can detect proteins at sub-nanogram levels 9,10 secreted PSA protein was detectable (Figure 3) . The Super-ELISA system can reproducibly detect PSA protein between 1 and 100 pg/ml (Figure 3a ) with remarkable linearity (R 2 40.998). The Super-ELISA system reproducibly detected PSA protein (2.0-5.7 pg/ml) from the cell culture medium in the presence or absence of 10 nM DHT or 10 nM R1881 (Figure 3b ). Ten nanomolar of DHT appeared to decrease PSA protein levels. This observation was consistent with changes in PSA mRNA levels assessed by QRT-PCR (Figure 3b, inset) . Previous reports AR functions in an African-American benign cell line K-H Kim et al from androgen responsive CaP cell lines of distinct origin indicated that PSA expression was increased in response to DHT. 19 Intriguingly, in RC-165N/hTERT cells secreted PSA protein levels were decreased, expression of PSA mRNA was decreased, and binding of AR to the AREIII enhancer of PSA gene was also decreased (Figure 2c ) in response to 10 nM DHT.
Androgen-regulated transcriptome in RC-165N/hTERT cells
To assess the expression of androgen-induced genes in RC-165N/hTERT cells, androgen-regulated transcriptome (ART) was analyzed. In this experiment cells were treated for 48 h with 1, 10 and 100 nM DHT and the expression profiles were normalized to 0 nM DHT-treated cells. Using the data computed from Affymetrix GeneChips, at an arbitrary cutoff of threefolds increases or oÀ3 folds decreases over the untreated control level of gene expression was applied to evaluate ART in RC-165N/hTERT cells. In RC-165N/hTERT cells, 99 genes were induced by DHT including known androgeninducible genes such as, NDRG1 and IGFBP3. Fortyone genes out of the 99 upregulated genes were previously reported in CaP and other cancers ( Table 1) . Thirteen of the 41 cancer-related genes were involved in prostate cancer. Out of the 13 genes, MGP was highly expressed in metastatic prostate tumor-derived cell lines. 20 and MT1 27 were shown to be associated with prostate cancer. The association of DHT-induced genes identified in RC-165N/hTERT cells with CaP support the potential of this cell culture model in evaluating the AR-signaling pathways involved in prostate epithelial cell growth and differentiation. Moreover, pathway analysis of the 13 identified prostate tumor associated genes indicated that some of these genes represent the endoplasmic reticulum stress response, fatty acid and cholesterol biosynthesis and polyamine biosynthesis pathways that is consistent with our previous studies in elucidating of androgen-regulated pathways in LNCaP cells 16 ( Figure 4a ). We found that 140 genes were repressed by DHT from B9696 expressed transcripts in RC-165N/ hTERT. The repression of 20 genes was consistent between the 1, 10 and 100 nM DHT treatment groups (Table 2) .
LNCaP cell line has been the prototypical model for evaluating ART in the context of prostate cell biology. Therefore, we compared published data on LNCaP-ART 16 to the RC165 N/hTERT -ART measurements (Figure 4b ). Fifty-two (54%) of the 96 previously described androgen-induced genes did show common expression changes in androgen-treated LNCaP and RC165 N/hTERT cells. Those 52 genes were categorized into two sub-classes. Thirty-three (63%) of the 52 genes showed consistent expression patterns in LNCaP and RC165 N/hTERT in response to androgens despite the different types of cell culture conditions or androgens (R1881 or DHT, respectively) were used in these experiments. Overall 33 (34.38%) genes out of the total 96 genes showed similar expression pattern in both the androgen-treated LNCaP cells and DHT-treated RC165 N/hTERT cells. This data supports that a significant component of AR signaling is intact in RC165 N/hTERT cells. 2 Furthermore, we found no evidence of p63 expression in this cell line arguing against basal cell origin. 3 As the RC-165N/ hTERT is the only available cell line derived from benign prostate tissue of an African-American CaP patient that stably expresses wt-AR, we characterized the biochemical functions of AR. Stable expression of AR is a requirement for a prostate epithelial cell model owing to its critical roles in prostate cell growth, differentiation and tumorigenesis. [28] [29] [30] Ligand-activated AR can regulate the transcription of a series of genes promoting growth and differentiation of male urogenital structures and the expression of prostate-specific markers such as PSA 31, 32 NKX3.1 [33] [34] [35] [36] and prostate-specific membrane antigen (PSMA). 32 The integrity of AR-signaling pathways in cell culture models is often assessed by addressing the question of whether or not AR-regulated genes are expressed and modulated in response to androgens. 37, 38 We found significant expression and regulation of three examined genes, PSMA (Figure 1b) , NDRG1 (Figure 1c ) and PMEPA1 (Figure 2a) by androgen treatment, which were also well characterized by others and us [16] [17] [18] 39 In comparison to LNCaP cells, the level of secreted PSA protein was substantially lower in RC-165N/hTERT cells (41:400 ratio). In RC-165N/hTERT cells, the downregulation of PSA at 10 nM DHT is a distinct response that is in contrast to androgen-sensitive CaP cells and may reflects inhibition of KLK3 gene transcription at and above 10 nM DHT. 31 This intriguing observation supported by ChIP as well as PSA (KLK3) QPCR assay that may in fact reflect the intrinsic nature of wt AR functions in RC165N/ hTERT cellular context.
As expected, analysis of the androgen inducible NDRG1 gene expression by QPCR and by microarray revealed consistent upregulation of the gene in response to DHT. Androgen-induced binding of AR to the upstream ARE of NDRG1 promoter supported these findings. 12 Although, we found the distal ARE occupied within the PMEPA1 promoter upstream sequences, the lack of AR binding at the proximal ARE is in contrast to our previous findings in LNCaP cells where binding of AR to both sites were required for the transcription activation of PMEPA1 gene. 12 We challenged RC165 N/hTERT cells with androgen hormone to evaluate the integrity of androgen signaling functions. The experiment revealed the activation of androgen-inducible genes as well as the expression of genes signifying cancer progression. However, the most important finding of the experiment was that pathways previously identified in cancer progression such as, endoplasmic reticulum stress response 16, 39 fatty acid and cholesterol biosynthesis, 40 and polyamine biosynthesis pathways 41 were activated in DHT-treated RC165 N/hTERT.
To reveal the similarities and differences between RC165 N/hTERT and LNCaP cells we compared androgen-induced gene expression changes between these two cell models. LNCaP cells are malignant cells harboring AR functions in an African-American benign cell line K-H Kim et al AR mutation. In contrast, RC165 N/hTERT cells are derived from a benign prostate gland followed by immortalization with telomerase harboring wt AR. The effects of mutation in AR have been well studied on in vivo malignant cell growth 42 and in vitro cell proliferation. 43 These studies suggested that the presence of mutation in AR could be responsible for diversified ARsignaling pathways, resulting in independent regulation of molecular events. The observed differences of androgen response transcriptome between LNCaP and RC165 N/hTERT highlight the contributions of both distinct nature of AR and the cellular context of the RC165N/ hTERT cells.
In this study, we characterized the RC-165N/hTERT cell line for AR and its functions. RC-165N/hTERT is a unique cell line derived from an African-American CaP patient's benign gland tissue. Wt AR in this cell line can bind to AR binding elements of target gene promoters in response to DHT. RC-165N/hTERT cells can express and secrete the prostate-specific antigen, however at very low levels. PSA expression is intriguingly downregulated with increasing androgen treatment in this cell line that may reflect the functions of a wt AR in a benign-derived cell line. GeneChip analysis demonstrated the expression of androgen-inducible genes in RC-165N/hTERT including known androgen-regulated and cancer progressionassociated genes and the subsequent pathway analysis supported these findings. Therefore, it is important to report the nature of androgen signaling in a benign prostate epithelium-derived cell line which might be illustrative for future studies of androgen-regulated genome in this type of cellular context. As AR is often lost in cell lines derived from primary prostate cancers and benign prostate, retention of AR expression and partial AR responsiveness of RC-165N/hTERT cells is suggestive of adaptive nature of AR signaling in a given cellular context. The unexpected DHT response of PSA regulation in RC-165N/hTERT cells may be revealing some aspect of AR functions during prostate epithelium growth and/or differentiation. In conclusion, RC-165N/ hTERT as benign prostate-derived epithelial cell culture model with wt AR expression and functional AR in many respects has potential utility as a new experimental model in prostate biology.
